fluorodeoxyglucose f18 has been researched along with gallium ga 68 dotatate in 69 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (2.90) | 29.6817 |
| 2010's | 49 (71.01) | 24.3611 |
| 2020's | 18 (26.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bomanji, JB; Caplin, M; Conway, G; Dickson, J; Ell, PJ; Gacinovic, S; Groves, A; Kayani, I; Win, T | 1 |
| Bomanji, JB; Caplin, M; Conry, BG; Kayani, I; Mahmood, S; Papathanasiou, ND; Prakash, V | 1 |
| Al-Nahhas, A; El-Refai, S; Hodolic, M; Khan, S; Marzola, MC; Naji, M; Rubello, D | 1 |
| Bomanji, JB; Caplin, M; Conry, BG; Dickson, J; Groves, AM; Kayani, I; Win, T | 1 |
| Bomanji, J; Caplin, M; Desai, K; Quigley, AM; Toumpanakis, C; Watkins, J; Woodward, N | 1 |
| Joshi, PV; Lele, VR | 1 |
| Abolmaali, N; Bornstein, SR; Därr, R; Eisenhofer, G; Gastmeier, J; Hofbauer, LC; Jelinek, V; Kamvissi, V; Wieczorek, K; Zöphel, K | 1 |
| Beck, M; Kuwert, T; Lell, MM; Navalpakkam, B; Quick, HH; Ritt, P; Schmidt, D; Uder, M; von Gall, CC; Wiesmüller, M | 1 |
| di Lenardo, F; Epstude, M; Hug, U; Riklin, C; Strobel, K; Tornquist, K; Winterhalder, R | 1 |
| Armbruster, M; Auernhammer, CJ; Haug, A; Ingrisch, M; Nikolaou, K; Paprottka, PM; Reiser, MF; Rist, C; Sommer, WH; Sourbron, S; Zech, CJ | 1 |
| Schembri, GP; Sounness, BD | 1 |
| Armbruster, M; Auernhammer, CJ; Ceelen, F; Haug, A; Reiser, MF; Rist, C; Singnurkar, A; Sommer, WH; Sourbron, S; Zech, CJ | 1 |
| Li, F; Wang, R; Xiao, J; Xing, B; Zhao, X; Zhu, Z | 1 |
| Agrawal, K; Bhadada, S; Bhansali, A; Bhattacharya, A; Mittal, BR; Shukla, J; Sood, A | 1 |
| Baum, RP; Kulkarni, HR | 2 |
| Bankstahl, JP; Bengel, FM; Korf-Klingebiel, M; Thackeray, JT; Walte, A; Wang, Y; Wittneben, A; Wollert, KC | 1 |
| Adalet, I; Aykan, F; Has Simsek, D; Kuyumcu, S; Sanlı, Y; Turkmen, C; Unal, S | 1 |
| Schillaci, O | 1 |
| Adalet, I; Aral, F; Gecer, MF; Kuyumcu, S; Ozel, S; Ozkan, ZG; Uzum, AK | 1 |
| Cardillo, G; De Waure, C; Filice, A; Giordano, A; Granone, P; Graziano, P; Lococo, F; Perotti, G; Rindi, G; Rossi, G; Rufini, V; Sgarbi, G; Stefanelli, A; Versari, A | 1 |
| Arridge, S; Atkinson, D; Barnes, A; Hutton, BF; Manber, R; O'Meara, C; Ourselin, S; Thielemans, K; Wan, S | 1 |
| Bagci, U; Papadakis, GZ; Patronas, NJ; Sadowski, SM; Stratakis, CA | 1 |
| Bagci, U; Millo, C; Papadakis, GZ; Patronas, NJ; Stratakis, CA | 1 |
| Adams, KT; Buchmann, I; Chen, CC; Fojo, AT; Herscovitch, P; Janssen, I; Kebebew, E; Millo, CM; Nambuba, J; Pacak, K; Patronas, NJ; Sadowski, SM; Taieb, D | 1 |
| Bilski, M; Duchnowska, R; Hryciuk, B; Kamiński, G; Szczylik, C; Szymanowski, B; Łapińska, G | 1 |
| Allkemper, T; Burg, MC; Heindel, W; Konnert, JR; Noto, B; Riemann, B; Schäfers, M; Stegger, L; Vrachimis, A; Weckesser, M; Wenning, C | 1 |
| Abdulrezzak, U; Kula, M; Kurt, YK; Tutus, A | 1 |
| Abdulelah, H; Al-Hussaini, M; Al-Ibraheem, A; AlSharif, A | 1 |
| Akhurst, TJ; Chang, CA; Hicks, RJ; Hofman, MS; Kong, G; Pattison, DA; Tothill, RW | 1 |
| Basuroy, R; Ramage, JK; Srirajaskanthan, R | 1 |
| Acar, E; Çapa Kaya, G; Durak, H | 1 |
| Akyel, R; Aydin, Y; Demirci, E; Elverdi, T; Erkan, ME; Halac, M; Ocak, M; Sonmezoglu, K; Vatankulu, B | 1 |
| Chan, M; Schembri, GP | 1 |
| Bagci, U; Jassel, IS; Karantanas, AH; Millo, C; Papadakis, GZ; Patronas, NJ; Sadowski, SM | 1 |
| Derlin, T; Hueper, K; Sohns, JM | 1 |
| Cuccurullo, V; Di Stasio, GD; Mansi, L; Prisco, MR | 1 |
| Narula, J; Strauss, HW | 1 |
| Huo, L; Jing, H; Li, F; Li, W; Wang, L; Wang, Z; Zhang, J | 1 |
| Mansberg, R; Russo, R; Szajer, J; Yung, G | 1 |
| Derlin, T; Hueper, K; Soudah, B | 1 |
| Cheng, G | 1 |
| Ahmadzadehfar, H; Alexander, N; Baruchel, S; Shammas, A; Vali, R | 1 |
| Li, F; Li, J; Luo, Y; Pan, Q; Zhang, S | 1 |
| Acar, E; Kaya, GÇ | 1 |
| Can, C; Kepenek, F; Komek, H; Urakçi, Z | 1 |
| Banezhad, F; Emami, F; Kiamanesh, Z; Sadeghi, R | 1 |
| Cheng, Z; Song, S; Zhu, X; Zou, S | 1 |
| Bajaj, N; Bibbo, CF; Blankstein, R; Bravo, PE; Di Carli, MF; Dorbala, S; Groarke, J; Hainer, J; Harrington, M; Hyun, H; Lakdawala, NK; Morgan, V; Padera, RF; Park, MA; Robertson, M; Stewart, GC | 1 |
| Lu, Y | 1 |
| Narula, J; Narula, N; Zubin Maslov, P | 1 |
| Adnan, A; Basu, S | 1 |
| Wan, DQ | 1 |
| Daube-Witherspoon, ME; Dubroff, JG; Karp, JS; Mankoff, DA; Muehllehner, G; Pantel, AR; Parma, MJ; Pryma, DA; Schubert, EK; Viswanath, V | 1 |
| Currie, GM; Sanchez, S | 1 |
| Aboagye, EO; Aloj, L; Bennett, MR; Fryer, TD; Gopalan, D; Manavaki, R; Mason, JC; Peters, JE; Rudd, JHF; Tarkin, JM; Wall, C | 1 |
| Ahmadzadehfar, H; Assadi, M; Dadgar, H; Norouzbeigi, N | 1 |
| Beg, M; De Blanche, L; Kandathil, A; Kazmi, S; Subramaniam, RM; You, H | 1 |
| Lan, X; Qin, C; Shao, F | 1 |
| Flamini, MEDM; Flamini, RC; Loureiro, LVM; Verçosa, AFA | 1 |
| Civan, C; Isik, EG; Simsek, DH | 1 |
| Liao, Z; Lu, Y; Luo, D; Pan, T; Thomas, MA | 1 |
| Angelico, G; Calcagni, ML; Lorusso, M; Quirino, M; Scolozzi, V | 1 |
| Arslan, E; Beyhan, E; Çermik, TF; Erol, Ö; Şahin, R | 1 |
| Pan, Y; Xie, J; Zhang, Y; Zhou, J | 1 |
| Cheng, S; Cheng, Z; Song, S; Zhu, X; Zou, S | 1 |
| Li, G; Li, L; Shen, G; Tian, R | 1 |
| Cai, J; Hu, X; Li, D; Wang, P; Wang, R | 1 |
| Bogusławska, A; Gamrat, A; Gilis-Januszewska, A; Hubalewska-Dydejczyk, A; Minasyan, M; Rzepka, E | 1 |
8 review(s) available for fluorodeoxyglucose f18 and gallium ga 68 dotatate
| Article | Year |
|---|---|
Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management.
Topics: Adrenal Gland Neoplasms; Adrenal Medulla; Carcinoma, Neuroendocrine; Catecholamines; Cushing Syndrome; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Organometallic Compounds; Parathyroid Neoplasms; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Patient Selection; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, X-Ray Computed | 2014 |
Theranostics with Ga-68 somatostatin receptor PET/CT: monitoring response to peptide receptor radionuclide therapy.
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Multimodal Imaging; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, X-Ray Computed | 2014 |
Neuroendocrine Tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Chromogranin A; Digestive System Surgical Procedures; Embolization, Therapeutic; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Hepatic Artery; Humans; Hydroxyindoleacetic Acid; Liver Neoplasms; Magnetic Resonance Imaging; Malignant Carcinoid Syndrome; Metastasectomy; Neoplasm Staging; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Serotonin; Tomography, X-Ray Computed | 2016 |
Nuclear Medicine in Patients with NET: Radiolabeled Somatostatin Analogues and their Brothers.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Somatostatin | 2017 |
Non-Small-Cell Lung Cancer PET Imaging Beyond F18 Fluorodeoxyglucose.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung; Lung Neoplasms; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Somatostatin | 2018 |
Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2018 |
Advances in Functional Imaging in the Assessment of Head and Neck Cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radioactive Tracers; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2019 |
1 trial(s) available for fluorodeoxyglucose f18 and gallium ga 68 dotatate
| Article | Year |
|---|---|
[(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2016 |
60 other study(ies) available for fluorodeoxyglucose f18 and gallium ga 68 dotatate
| Article | Year |
|---|---|
Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Gallium; Humans; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2008 |
Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Receptors, Somatostatin; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
Use of molecular imaging to differentiate liver metastasis of colorectal cancer metastasis from neuroendocrine tumor origin.
Topics: Biopsy; Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography | 2011 |
Unexpected visitor on FDG PET/CT--brown adipose tissue (BAT) in mesentery in a case of retroperitoneal extra-adrenal pheochromocytoma: is the BAT activation secondary to catecholamine-secreting pheochromocytoma?
Topics: Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adult; Catecholamines; Fluorodeoxyglucose F18; Humans; Male; Mesentery; Multimodal Imaging; Organometallic Compounds; Pheochromocytoma; Positron-Emission Tomography; Retroperitoneal Space; Tomography, X-Ray Computed | 2012 |
Combined use of 68Ga-DOTATATE and 18F-FDG PET/CT to localize a bronchial carcinoid associated with ectopic ACTH syndrome.
Topics: ACTH Syndrome, Ectopic; Aged; Carcinoid Tumor; Carcinoma, Bronchogenic; Drug Combinations; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Organometallic Compounds; Pituitary ACTH Hypersecretion; Radionuclide Imaging | 2012 |
Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Comparison of (18)F-FDG PET/CT and (68)Ga-DOTATATE PET/CT imaging in metastasized Merkel cell carcinoma.
Topics: Aged, 80 and over; Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Organometallic Compounds; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2013 |
Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Topics: Contrast Media; Coordination Complexes; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
68Ga-dotatate avid medullary thyroid cancer with occult liver metastases.
Topics: Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Thyroid Neoplasms | 2014 |
Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy.
Topics: Adenoma; Adult; Cicatrix; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Organometallic Compounds; Pituitary Gland; Pituitary Neoplasms; Radionuclide Imaging; Sphenoid Bone | 2014 |
Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Connective Tissue; Organometallic Compounds; Osteomalacia; Paraneoplastic Syndromes; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Targeting post-infarct inflammation by PET imaging: comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model.
Topics: Animals; Citrates; Fluorodeoxyglucose F18; Gallium; Inflammation; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Perfusion Imaging; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intestinal Neoplasms; Ki-67 Antigen; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Can PET/CT guide the personalized treatment of patients with gastroenteropancreatic neuroendocrine neoplasms?
Topics: Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Comparison of ⁶⁸Ga-DOTATATE PET-CT, ¹⁸F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm, Residual; Organometallic Compounds; Positron-Emission Tomography; Retrospective Studies; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2015 |
Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid.
Topics: Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Practical PET Respiratory Motion Correction in Clinical PET/MR.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Artifacts; Calibration; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Movement; Multimodal Imaging; Organometallic Compounds; Positron-Emission Tomography; Respiration | 2015 |
Ectopic ACTH and CRH Co-secreting Tumor Localized by 68Ga-DOTA-TATE PET/CT.
Topics: Adrenocorticotropic Hormone; Corticotropin-Releasing Hormone; Cushing Syndrome; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
Talc Pleurodesis With Intense 18F-FDG Activity But No 68Ga-DOTA-TATE Activity on PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Organometallic Compounds; Pleural Effusion; Pleurodesis; Positron-Emission Tomography; Radiopharmaceuticals; Talc; Tomography, X-Ray Computed | 2015 |
68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Paraganglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed | 2016 |
Problems of diagnostic assessment in advanced pancreatic neuroendocrine neoplasm and treatment implications: a case report and literature review.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors.
Topics: Adult; Aged; Drug Combinations; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2016 |
Synchronous presentation of nasopharyngeal carcinoma and abdominal paraganglioma with avid 18F-FDG and 68Ga-DOTA-TOC uptake in PET/CT by both tumours.
Topics: Abdominal Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasms, Multiple Primary; Organometallic Compounds; Paraganglioma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tissue Distribution | 2016 |
(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Hepatopulmonary Shunt Reduction With 177Lu-DOTATATE Therapy.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
The role of 68Ga-DOTA-TATE PET/CT scanning in the evaluation of patients with multiple myeloma: preliminary results.
Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Multiple Myeloma; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2017 |
Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
18F-FDG and 68Ga-DOTATATE PET/CT in von Hippel-Lindau Disease-Associated Retinal Hemangioblastoma.
Topics: Adult; Fluorodeoxyglucose F18; Gallium Radioisotopes; Hemangioblastoma; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Retinal Neoplasms; von Hippel-Lindau Disease | 2017 |
68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Chordoma: Comparison With 18F-FDG.
Topics: Chordoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Imaging Vulnerable Plaque: A Medical Necessity or a Scientific Curiosity?
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Organometallic Compounds; Plaque, Atherosclerotic; Positron-Emission Tomography | 2017 |
Comparison of the 68Ga-DOTATATA PET/CT, FDG PET/CT, and MIBG SPECT/CT in the Evaluation of Suspected Primary Pheochromocytomas and Paragangliomas.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography | 2017 |
Adrenocorticotropic Hormone-Secreting Neuroendocrine Tumor of the Rectum Demonstrated on 68Ga-DOTATATE and 18F-FDG PET Imaging.
Topics: Adrenocorticotropic Hormone; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Rectal Neoplasms | 2017 |
68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Epithelioid Hemangioendothelioma: Comparison With 18F-FDG.
Topics: Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Hemangioendothelioma, Epithelioid; Humans; Middle Aged; Molecular Imaging; Neoplasm Metastasis; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Receptors, Somatostatin | 2017 |
Recurrence of Extramedullary Plasmacytomas Involving Lymph Nodes and Pancreas Revealed by 68Ga-DOTATATE and 18F-FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Lymph Nodes; Male; Neuroendocrine Tumors; Nose Neoplasms; Organometallic Compounds; Pancreatic Neoplasms; Plasmacytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2018 |
18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
Topics: Aged; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Metastasis; Neuroendocrine Tumors; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2019 |
Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
Topics: Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
68Ga DOTATATE PET/CT Versus 18F-FDG PET/CT for Detecting Intramedullary Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.
Topics: Adult; Cerebellar Neoplasms; Fluorodeoxyglucose F18; Hemangioblastoma; Humans; Male; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Receptors, Somatostatin; von Hippel-Lindau Disease | 2019 |
Concurrent Metastatic Pheochromocytomas and Lung Adenocarcinoma on 18F-FDG and 68Ga-DOTATATE PET/CT Images.
Topics: Adenocarcinoma of Lung; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Organometallic Compounds; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2019 |
Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study.
Topics: Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Organometallic Compounds; Pilot Projects; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Sarcoidosis; Sensitivity and Specificity | 2021 |
Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT.
Topics: Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multiple Myeloma; Neoplasm Grading; Neoplasms, Multiple Primary; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2019 |
Somatostatin receptor imaging in active cardiac sarcoidosis: Would less be enough?
Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sarcoidosis; Sensitivity and Specificity | 2021 |
Well-differentiated grade 3 neuroendocrine tumours and poorly differentiated grade 3 neuroendocrine carcinomas: will dual tracer PET-computed tomography (68Ga-DOTATATE and FDG) play a pivotal role in differentiation and guiding management strategies?
Topics: Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Grading; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2019 |
PennPET Explorer: Human Imaging on a Whole-Body Imager.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Healthy Volunteers; Humans; Image Processing, Computer-Assisted; Kinetics; Male; Middle Aged; Organometallic Compounds; Phantoms, Imaging; Positron-Emission Tomography; Whole Body Imaging | 2020 |
Topical Sensor for the Assessment of Injection Quality for 18F-FDG, 68Ga-PSMA and 68Ga-DOTATATE Positron Emission Tomography.
Topics: Aged; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Injections; Male; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Quality Improvement; Radiopharmaceuticals; Retrospective Studies; Risk Factors | 2020 |
Novel Approach to Imaging Active Takayasu Arteritis Using Somatostatin Receptor Positron Emission Tomography/Magnetic Resonance Imaging.
Topics: Adult; Aorta; Biomarkers; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Middle Aged; Molecular Imaging; Organometallic Compounds; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin; Takotsubo Cardiomyopathy; Treatment Outcome | 2020 |
68Ga-DOTATATE and 18F-FDG PET/CT for the Management of Esthesioneuroblastoma of the Sphenoclival Region.
Topics: Esthesioneuroblastoma, Olfactory; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Nasal Cavity; Nose Neoplasms; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Receptors, Somatostatin | 2020 |
Ga-68 DOTATATE PET/CT and F-18 FDG PET/CT in the evaluation of low and intermediate versus high-grade neuroendocrine tumors.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2020 |
Diffuse Increased 68Ga-DOTATATE But Unimpressive 18F-FDG Osseous Activity in a Patient With Rapid-Progressing Synchronous Multifocal Osteosarcoma.
Topics: Adolescent; Bone and Bones; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Organometallic Compounds; Osteosarcoma; Positron Emission Tomography Computed Tomography | 2020 |
68Ga-DOTATATE and 18F-FDG in Castleman Disease.
Topics: Adult; Castleman Disease; Female; Fluorodeoxyglucose F18; Humans; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2020 |
Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.
Topics: Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Metastasis; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2021 |
New Data-Driven Gated PET/CT Free of Misregistration Artifacts.
Topics: Artifacts; Body Mass Index; Data Science; Exhalation; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Lung Neoplasms; Organ Motion; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Exposure; Radiotherapy Dosage; Respiratory Mechanics; Time Factors; Tomography, X-Ray Computed | 2021 |
18F-FDG and 68Ga-DOTATOC PET/CT Findings in a Case of Abdominal Leiomyosarcoma.
Topics: Abdominal Neoplasms; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Detection of Cauda Equine Syndrome With 18F-FDG PET/CT and Leptomeningeal Metastasis by 68Ga-DOTATATE in the Same Patient With Large Cell Neuroendocrine Carcinoma of Lung.
Topics: Cauda Equina Syndrome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Meningeal Neoplasms; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2021 |
Detection of Adult Pancreatoblastoma by 18F-FDG and 68Ga-DOTATATE PET/MR.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Multimodal Imaging; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography | 2021 |
Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2021 |
Increased 68Ga-DOTATATE Uptake in Supraclavicular Brown Adipose Tissue.
Topics: Adipose Tissue, Brown; Biological Transport; Fluorodeoxyglucose F18; Humans; Male | 2022 |
Comparison of the application of 18F-FDG and 68Ga-DOTATATE PET/CT in neuroendocrine tumors: A retrospective study.
Topics: Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Ectopic, CRH-responsive Cushing syndrome with negative 68Ga-DOTATATE and 18F-FDG PET/CT imaging findings and pituitary microadenoma: a challenging case with a successful outcome.
Topics: Cushing Syndrome; Fluorodeoxyglucose F18; Humans; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |